Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The win ratio method allows for the integration of mortality, clinical events, and patient-reported outcomes to efficiently evaluate new treatments in heart failure trials.
The EMPULSE trial findings illustrate how deaths, clinical events and patient-reported outcomes can be integrated into a win ratio analysis strategy that yields clinically meaningful findings of patient benefit. This has implications for future trial designs that recognize the clinical priorities of patient evaluation and the need for efficient progress towards approval of new treatments.
No takes yet. Share an insight, caveat, or question.
Pocock et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: